INVITED RESEARCH HIGHLIGHT
Ahead of Print

Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer


 GU Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA 22031, USA

Correspondence Address:
Jeanny B Aragon-Ching,
GU Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA 22031
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/aja.aja_52_19

PMID: 31249268



[FULL TEXT] [PDF]
Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Aragon-Ching JB
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed997    
    PDF Downloaded99    

Recommend this journal